[HTML] sciencedirect.com

[HTML][HTML] EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells

CY Liu, TT Huang, CT Huang, MH Hu, DS Wang… - European journal of …, 2017 - Elsevier
Objectives Cancerous inhibitor of protein phosphatase 2A (CIP2A) has emerged as a
therapeutic determinant mediating the anti-cancer effects of several new agents. We …
被引用次数：39 相关文章

EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells

CY Liu, TT Huang, CT Huang, MH Hu… - European Journal of …, 2017 - scholar.nycu.edu.tw
Objectives Cancerous inhibitor of protein phosphatase 2A (CIP2A) has emerged as a
therapeutic determinant mediating the anti-cancer effects of several new agents. We …

EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells

CY Liu, TT Huang, CT Huang, MH Hu… - European Journal of …, 2017 - ejcancer.com
Objectives Cancerous inhibitor of protein phosphatase 2A (CIP2A) has emerged as a
therapeutic determinant mediating the anti-cancer effects of several new agents. We …

EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells

CY Liu, TT Huang, CT Huang, MH Hu, DS Wang… - European Journal of …, 2017 - infona.pl
Cancerous inhibitor of protein phosphatase 2A (CIP2A) has emerged as a therapeutic
determinant mediating the anti-cancer effects of several new agents. We investigated the …
[PDF] tccf.org.tw

[PDF][PDF] EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells

CY Liu, TT Huang, CT Huang, MH Hu… - European Journal of …, 2017 - tccf.org.tw
EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative
TD52 in triple-negative breast cance Page 1 Original Research EGFR-independent Elk1/CIP2A …

EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells

CY Liu, TT Huang, CT Huang… - … journal of cancer …, 2017 - pubmed.ncbi.nlm.nih.gov
Objectives Cancerous inhibitor of protein phosphatase 2A (CIP2A) has emerged as a
therapeutic determinant mediating the anti-cancer effects of several new agents. We …

EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells.

CY Liu, TT Huang, CT Huang, MH Hu… - European Journal of …, 2016 - europepmc.org
Objectives Cancerous inhibitor of protein phosphatase 2A (CIP2A) has emerged as a
therapeutic determinant mediating the anti-cancer effects of several new agents. We …

EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells

CY Liu, TT Huang, CT Huang, MH Hu… - European Journal of …, 2017 - hub.tmu.edu.tw
Objectives Cancerous inhibitor of protein phosphatase 2A (CIP2A) has emerged as a
therapeutic determinant mediating the anti-cancer effects of several new agents. We …

EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells

CY Liu, TT Huang, CT Huang, MH Hu, DS Wang… - European Journal of …, 2017 - infona.pl
Cancerous inhibitor of protein phosphatase 2A (CIP2A) has emerged as a therapeutic
determinant mediating the anti-cancer effects of several new agents. We investigated the …

EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells

CY Liu, TT Huang, CT Huang, MH Hu… - European Journal of …, 2017 - hub.tmu.edu.tw
Objectives Cancerous inhibitor of protein phosphatase 2A (CIP2A) has emerged as a
therapeutic determinant mediating the anti-cancer effects of several new agents. We …